Uterine Fibroids are the abnormal growth that gets developed inside or on the wall of a woman’s uterus. These are also known as leiomyoma or myomas. These are noncancerous growths that cause symptoms such as heavy bleeding between or during the menstrual cycle, pain in pelvis or lower back, increased menstrual cramping, swelling enlargement of the abdomen. Increasing prevalence due to heredity and rising number of treatments to cure this disease has fuelled the growth of this market.
The U.S. Market for Uterine Fibroids is expected to reach USD 39,993.2 million by the end of the forecasted period and is expected to grow at a CAGR of 3.24%.
Uterine Fibroid Market Segmentation:
U.S. Uterine Fibroid Market has been segmented on the basis of type which comprises of Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others. On the basis of diagnosis the market is segmented into Medical Resonance Imaging (MRI) scanners, Computed tomography (CT), Ultrasounds and others. On the basis of treatment the market is segmented into Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2394
Intended Audience
- Uterine Fibroid Devices and Drug Manufacturers
- Uterine Fibroid Devices and Drug Suppliers
- Private Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Medical Research Laboratories
Key Players
Some of the key players in the global Uterine Fibroid market are STERIS Corporation (U.K.), Getinge Group (Sweden), Cantel Medical Corporation (U.S.), Ecolab (U.S.), 3M Healthcare Company (U.S.), Sotera Health (U.S.), Advanced Sterilization Products (U.S.), MMM Group (Germany), Matachana (Spain), Belimed AG (Switzerland), Halyard Health (U.S.), Metrex Research (U.S.), Reckitt Benckiser (U.K.), Pal Internation (U.K.), Nordion, Inc. (U.S.), Ahlstrom Corporation (Finland), Honeywell International, Inc. (U.S.), and others.
Regional Analysis
The U.S. market for uterine fibroids is growing steadily. The market for uterine fibroids is growing with the CAGR of 3.24% during the forecast period from 2016-2022. California, Texas, Florida, New York are some of the states which are estimated to have highest prevalence of uterine fibroids.
The report for U.S. Uterine Fibroid Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Table Of Content
1. Introduction
1.1.1 Prevalence Of The Uterine Fibroids In U.S. 8
2. Scope of Study
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
4. US Uterine Fibroid Market
4.1 Introduction 15
4.2 U.S. Uterine Fibroid Market, By Type 17
4.3 U.S. Uterine Fibroid Market, By Diagnosis 19
4.4 U.S. Uterine Fibroid Market, By Treatment 21
TOC Continued….!
Browse Complete Report Details @
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
No comments:
Post a Comment